APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Tafamidis Meglumine Soft Capsules

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Tafamidis Meglumine Soft Capsules Industry Growth and Trends Forecast to 2032

Report ID 174039610127 December 202571 pages

Choose your research edition.

Industry ResearchTafamidis Meglumine Soft Capsules Industry Research Report 2026107 pages · $2,950 USDIndustry Growth & TrendsGlobal Tafamidis Meglumine Soft Capsules Industry Growth and Trends Forecast to 203271 pages · $3,450 USDMarket StructureGlobal Tafamidis Meglumine Soft Capsules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032175 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Tafamidis Meglumine Soft Capsules Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Tafamidis Meglumine Soft Capsules Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Tafamidis Meglumine Soft Capsules market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Tafamidis Meglumine Soft Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Tafamidis Meglumine Soft Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Tafamidis Meglumine Soft Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Tafamidis Meglumine Soft Capsules include Chia Tai Tianqing Pharmaceutical, Qilu Pharmaceutical and Pfizer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Tafamidis Meglumine Soft Capsules market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Tafamidis Meglumine Soft Capsules market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Tafamidis Meglumine Soft Capsules market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Tafamidis Meglumine Soft Capsules.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Tafamidis Meglumine Soft Capsules market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Tafamidis Meglumine Soft Capsules Market by Company

Chia Tai Tianqing Pharmaceutical

Qilu Pharmaceutical

Pfizer

Tafamidis Meglumine Soft Capsules Segment by Type

Generic Drug

Original Drug

Tafamidis Meglumine Soft Capsules Segment by Application

Retail Pharmacies

Hospital and Clinic

Other

Tafamidis Meglumine Soft Capsules Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tafamidis Meglumine Soft Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Tafamidis Meglumine Soft Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tafamidis Meglumine Soft Capsules.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Tafamidis Meglumine Soft Capsules manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Tafamidis Meglumine Soft Capsules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Generic Drug Table 2. Major Company of Original Drug Table 3. Global Tafamidis Meglumine Soft Capsules Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Tafamidis Meglumine Soft Capsules Sales by Type (2021-2026) & (K Units) Table 5. Global Tafamidis Meglumine Soft Capsules Sales Market Share in Volume by Type (2021-2026) Table 6. Global Tafamidis Meglumine Soft Capsules Sales by Type (2021-2026) & (US$ Million) Table 7. Global Tafamidis Meglumine Soft Capsules Sales Market Share in Value by Type (2021-2026) Table 8. Global Tafamidis Meglumine Soft Capsules Price by Type (2021-2026) & (US$/Unit) Table 9. Global Tafamidis Meglumine Soft Capsules Sales by Type (2027-2032) & (K Units) Table 10. Global Tafamidis Meglumine Soft Capsules Sales Market Share in Volume by Type (2027-2032) Table 11. Global Tafamidis Meglumine Soft Capsules Sales by Type (2027-2032) & (US$ Million) Table 12. Global Tafamidis Meglumine Soft Capsules Sales Market Share in Value by Type (2027-2032) Table 13. Global Tafamidis Meglumine Soft Capsules Price by Type (2027-2032) & (US$/Unit) Table 14. North America Tafamidis Meglumine Soft Capsules Sales by Type (2021-2026) & (K Units) Table 15. North America Tafamidis Meglumine Soft Capsules Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Tafamidis Meglumine Soft Capsules Sales by Type (2021-2026) & (K Units) Table 17. Europe Tafamidis Meglumine Soft Capsules Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Tafamidis Meglumine Soft Capsules Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Tafamidis Meglumine Soft Capsules Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Tafamidis Meglumine Soft Capsules Sales by Type (2021-2026) & (K Units) Table 21. Latin America Tafamidis Meglumine Soft Capsules Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Tafamidis Meglumine Soft Capsules Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Tafamidis Meglumine Soft Capsules Sales by Type (2021-2026) & (US$ Million) Table 24. Tafamidis Meglumine Soft Capsules Industry Trends Table 25. Tafamidis Meglumine Soft Capsules Industry Drivers Table 26. Tafamidis Meglumine Soft Capsules Industry Opportunities and Challenges Table 27. Tafamidis Meglumine Soft Capsules Industry Restraints Table 28. Global Tafamidis Meglumine Soft Capsules Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Tafamidis Meglumine Soft Capsules Revenue Market Share by Company (2021-2026) Table 30. Global Tafamidis Meglumine Soft Capsules Sales by Company (2021-2026) & (K Units) Table 31. Global Tafamidis Meglumine Soft Capsules Sales Share by Company (2021-2026) Table 32. Global Tafamidis Meglumine Soft Capsules Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Tafamidis Meglumine Soft Capsules Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Tafamidis Meglumine Soft Capsules Major Company Production Sites and Headquarters Table 35. Global Tafamidis Meglumine Soft Capsules Company, Product Type & Application Table 36. Global Tafamidis Meglumine Soft Capsules Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Tafamidis Meglumine Soft Capsules by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Tafamidis Meglumine Soft Capsules Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Tafamidis Meglumine Soft Capsules Sales by Region (2021-2026) & (K Units) Table 41. Global Tafamidis Meglumine Soft Capsules Sales Market Share in Volume by Region (2021-2026) Table 42. Global Tafamidis Meglumine Soft Capsules Sales by Region (2021-2026) & (US$ Million) Table 43. Global Tafamidis Meglumine Soft Capsules Sales Market Share in Value by Region (2021-2026) Table 44. Global Tafamidis Meglumine Soft Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Tafamidis Meglumine Soft Capsules Sales by Region (2027-2032) & (K Units) Table 46. Global Tafamidis Meglumine Soft Capsules Sales Market Share in Volume by Region (2027-2032) Table 47. Global Tafamidis Meglumine Soft Capsules Sales by Region (2027-2032) & (US$ Million) Table 48. Global Tafamidis Meglumine Soft Capsules Sales Market Share in Value by Region (2027-2032) Table 49. Global Tafamidis Meglumine Soft Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Tafamidis Meglumine Soft Capsules Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Tafamidis Meglumine Soft Capsules Sales by Application (2021-2026) & (K Units) Table 52. Global Tafamidis Meglumine Soft Capsules Sales Market Share in Volume by Application (2021-2026) Table 53. Global Tafamidis Meglumine Soft Capsules Sales by Application (2021-2026) & (US$ Million) Table 54. Global Tafamidis Meglumine Soft Capsules Sales Market Share in Value by Application (2021-2026) Table 55. Global Tafamidis Meglumine Soft Capsules Price by Application (2021-2026) & (US$/Unit) Table 56. Global Tafamidis Meglumine Soft Capsules Sales by Application (2027-2032) & (K Units) Table 57. Global Tafamidis Meglumine Soft Capsules Sales Market Share in Volume by Application (2027-2032) Table 58. Global Tafamidis Meglumine Soft Capsules Sales by Application (2027-2032) & (US$ Million) Table 59. Global Tafamidis Meglumine Soft Capsules Sales Market Share in Value by Application (2027-2032) Table 60. Global Tafamidis Meglumine Soft Capsules Price by Application (2027-2032) & (US$/Unit) Table 61. North America Tafamidis Meglumine Soft Capsules Sales by Application (2021-2026) & (K Units) Table 62. North America Tafamidis Meglumine Soft Capsules Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Tafamidis Meglumine Soft Capsules Sales by Application (2021-2026) & (K Units) Table 64. Europe Tafamidis Meglumine Soft Capsules Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Tafamidis Meglumine Soft Capsules Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Tafamidis Meglumine Soft Capsules Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Tafamidis Meglumine Soft Capsules Sales by Application (2021-2026) & (K Units) Table 68. Latin America Tafamidis Meglumine Soft Capsules Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Tafamidis Meglumine Soft Capsules Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Tafamidis Meglumine Soft Capsules Sales by Application (2021-2026) & (US$ Million) Table 71. Chia Tai Tianqing Pharmaceutical Company Information Table 72. Chia Tai Tianqing Pharmaceutical Business Overview Table 73. Chia Tai Tianqing Pharmaceutical Tafamidis Meglumine Soft Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Chia Tai Tianqing Pharmaceutical Tafamidis Meglumine Soft Capsules Product Portfolio Table 75. Chia Tai Tianqing Pharmaceutical Recent Development Table 76. Qilu Pharmaceutical Company Information Table 77. Qilu Pharmaceutical Business Overview Table 78. Qilu Pharmaceutical Tafamidis Meglumine Soft Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Qilu Pharmaceutical Tafamidis Meglumine Soft Capsules Product Portfolio Table 80. Qilu Pharmaceutical Recent Development Table 81. Pfizer Company Information Table 82. Pfizer Business Overview Table 83. Pfizer Tafamidis Meglumine Soft Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Pfizer Tafamidis Meglumine Soft Capsules Product Portfolio Table 85. Pfizer Recent Development Table 86. North America Tafamidis Meglumine Soft Capsules Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 87. North America Tafamidis Meglumine Soft Capsules Sales by Country (2021-2026) & (K Units) Table 88. North America Tafamidis Meglumine Soft Capsules Sales Market Share by Country (2021-2026) Table 89. North America Tafamidis Meglumine Soft Capsules Sales Forecast by Country (2027-2032) & (K Units) Table 90. North America Tafamidis Meglumine Soft Capsules Sales Market Share Forecast by Country (2027-2032) Table 91. North America Tafamidis Meglumine Soft Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 92. North America Tafamidis Meglumine Soft Capsules Market Size by Country (2021-2026) & (US$ Million) Table 93. North America Tafamidis Meglumine Soft Capsules Market Share by Country (2021-2026) Table 94. North America Tafamidis Meglumine Soft Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 95. North America Tafamidis Meglumine Soft Capsules Market Share Forecast by Country (2027-2032) Table 96. Europe Tafamidis Meglumine Soft Capsules Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 97. Europe Tafamidis Meglumine Soft Capsules Sales by Country (2021-2026) & (K Units) Table 98. Europe Tafamidis Meglumine Soft Capsules Sales Market Share by Country (2021-2026) Table 99. Europe Tafamidis Meglumine Soft Capsules Sales Forecast by Country (2027-2032) & (K Units) Table 100. Europe Tafamidis Meglumine Soft Capsules Sales Market Share Forecast by Country (2027-2032) Table 101. Europe Tafamidis Meglumine Soft Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 102. Europe Tafamidis Meglumine Soft Capsules Market Size by Country (2021-2026) & (US$ Million) Table 103. Europe Tafamidis Meglumine Soft Capsules Market Share by Country (2021-2026) Table 104. Europe Tafamidis Meglumine Soft Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 105. Europe Tafamidis Meglumine Soft Capsules Market Share Forecast by Country (2027-2032) Table 106. Asia-Pacific Tafamidis Meglumine Soft Capsules Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 107. Asia-Pacific Tafamidis Meglumine Soft Capsules Sales by Country (2021-2026) & (K Units) Table 108. Asia-Pacific Tafamidis Meglumine Soft Capsules Sales Market Share by Country (2021-2026) Table 109. Asia-Pacific Tafamidis Meglumine Soft Capsules Sales Forecast by Country (2027-2032) & (K Units) Table 110. Asia-Pacific Tafamidis Meglumine Soft Capsules Sales Market Share Forecast by Country (2027-2032) Table 111. Asia-Pacific Tafamidis Meglumine Soft Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. Asia-Pacific Tafamidis Meglumine Soft Capsules Market Size by Country (2021-2026) & (US$ Million) Table 113. Asia-Pacific Tafamidis Meglumine Soft Capsules Market Share by Country (2021-2026) Table 114. Asia-Pacific Tafamidis Meglumine Soft Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. Asia-Pacific Tafamidis Meglumine Soft Capsules Market Share Forecast by Country (2027-2032) Table 116. Latin America Tafamidis Meglumine Soft Capsules Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 117. Latin America Tafamidis Meglumine Soft Capsules Sales by Country (2021-2026) & (K Units) Table 118. Latin America Tafamidis Meglumine Soft Capsules Sales Market Share by Country (2021-2026) Table 119. Latin America Tafamidis Meglumine Soft Capsules Sales Forecast by Country (2027-2032) & (K Units) Table 120. Latin America Tafamidis Meglumine Soft Capsules Sales Market Share Forecast by Country (2027-2032) Table 121. Latin America Tafamidis Meglumine Soft Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Latin America Tafamidis Meglumine Soft Capsules Market Size by Country (2021-2026) & (US$ Million) Table 123. Latin America Tafamidis Meglumine Soft Capsules Market Share by Country (2021-2026) Table 124. Latin America Tafamidis Meglumine Soft Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Latin America Tafamidis Meglumine Soft Capsules Market Share Forecast by Country (2027-2032) Table 126. Middle East and Africa Tafamidis Meglumine Soft Capsules Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 127. Middle East and Africa Tafamidis Meglumine Soft Capsules Sales by Country (2021-2026) & (K Units) Table 128. Middle East and Africa Tafamidis Meglumine Soft Capsules Sales Market Share by Country (2021-2026) Table 129. Middle East and Africa Tafamidis Meglumine Soft Capsules Sales Forecast by Country (2027-2032) & (K Units) Table 130. Middle East and Africa Tafamidis Meglumine Soft Capsules Sales Market Share Forecast by Country (2027-2032) Table 131. Middle East and Africa Tafamidis Meglumine Soft Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Middle East and Africa Tafamidis Meglumine Soft Capsules Market Size by Country (2021-2026) & (US$ Million) Table 133. Middle East and Africa Tafamidis Meglumine Soft Capsules Market Share by Country (2021-2026) Table 134. Middle East and Africa Tafamidis Meglumine Soft Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Middle East and Africa Tafamidis Meglumine Soft Capsules Market Share Forecast by Country (2027-2032) Table 136. Key Raw Materials Table 137. Raw Materials Key Suppliers Table 138. Tafamidis Meglumine Soft Capsules Distributors List Table 139. Tafamidis Meglumine Soft Capsules Customers List Table 140. Research Programs/Design for This Report Table 141. Authors List of This Report Table 142. Secondary Sources Table 143. Primary Sources List of Figures Figure 1. Tafamidis Meglumine Soft Capsules Image Figure 2. Global Tafamidis Meglumine Soft Capsules Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Tafamidis Meglumine Soft Capsules Market Size (2021-2032) & (US$ Million) Figure 4. Global Tafamidis Meglumine Soft Capsules Sales (2021-2032) & (K Units) Figure 5. Generic Drug Image Figure 6. Global Generic Drug Sales YoY Growth (2021-2032) & (K Units) Figure 7. Original Drug Image Figure 8. Global Original Drug Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Tafamidis Meglumine Soft Capsules Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Tafamidis Meglumine Soft Capsules Market Share by Type 2025 VS 2032 Figure 11. North America Tafamidis Meglumine Soft Capsules Sales Market Share in Volume by Type in 2025 Figure 12. North America Tafamidis Meglumine Soft Capsules Sales Market Share in Value by Type in 2025 Figure 13. Europe Tafamidis Meglumine Soft Capsules Sales Market Share in Volume by Type in 2025 Figure 14. Europe Tafamidis Meglumine Soft Capsules Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Tafamidis Meglumine Soft Capsules Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Tafamidis Meglumine Soft Capsules Sales Market Share in Value by Type in 2025 Figure 17. Latin America Tafamidis Meglumine Soft Capsules Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Tafamidis Meglumine Soft Capsules Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Tafamidis Meglumine Soft Capsules Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Tafamidis Meglumine Soft Capsules Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Tafamidis Meglumine Soft Capsules Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Retail Pharmacies Image Figure 24. Global Retail Pharmacies Sales YoY Growth (2021-2032) & (K Units) Figure 25. Hospital and Clinic Image Figure 26. Global Hospital and Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 27. Other Image Figure 28. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Tafamidis Meglumine Soft Capsules Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Tafamidis Meglumine Soft Capsules Market Share by Application 2025 VS 2032 Figure 31. North America Tafamidis Meglumine Soft Capsules Sales Market Share in Volume by Application in 2025 Figure 32. North America Tafamidis Meglumine Soft Capsules Sales Market Share in Value by Application in 2025 Figure 33. Europe Tafamidis Meglumine Soft Capsules Sales Market Share in Volume by Application in 2025 Figure 34. Europe Tafamidis Meglumine Soft Capsules Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Tafamidis Meglumine Soft Capsules Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Tafamidis Meglumine Soft Capsules Sales Market Share in Value by Application in 2025 Figure 37. Latin America Tafamidis Meglumine Soft Capsules Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Tafamidis Meglumine Soft Capsules Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Tafamidis Meglumine Soft Capsules Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Tafamidis Meglumine Soft Capsules Sales Market Share in Value by Application in 2025 Figure 41. North America Tafamidis Meglumine Soft Capsules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Tafamidis Meglumine Soft Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Tafamidis Meglumine Soft Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Tafamidis Meglumine Soft Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Tafamidis Meglumine Soft Capsules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Tafamidis Meglumine Soft Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Tafamidis Meglumine Soft Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Tafamidis Meglumine Soft Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Tafamidis Meglumine Soft Capsules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Tafamidis Meglumine Soft Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Tafamidis Meglumine Soft Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Tafamidis Meglumine Soft Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Tafamidis Meglumine Soft Capsules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Tafamidis Meglumine Soft Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Tafamidis Meglumine Soft Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Tafamidis Meglumine Soft Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Tafamidis Meglumine Soft Capsules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Tafamidis Meglumine Soft Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Tafamidis Meglumine Soft Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Tafamidis Meglumine Soft Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Tafamidis Meglumine Soft Capsules Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Tafamidis Meglumine Soft Capsules Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Generic Drug
  • Original Drug
Applications
  • Retail Pharmacies
  • Hospital and Clinic
  • Other
Companies covered
  • Chia Tai Tianqing Pharmaceutical
  • Qilu Pharmaceutical
  • Pfizer

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Tafamidis Meglumine Soft Capsules Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Tafamidis Meglumine Soft Capsules Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Tafamidis Meglumine Soft Capsules Market by Type
  6. 1.3.1 Generic Drug
  7. 1.3.2 Original Drug
  8. 1.4 Global Tafamidis Meglumine Soft Capsules Market Size by Type
  9. 1.4.1 Global Tafamidis Meglumine Soft Capsules Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Tafamidis Meglumine Soft Capsules Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Tafamidis Meglumine Soft Capsules Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Tafamidis Meglumine Soft Capsules Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Tafamidis Meglumine Soft Capsules Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Tafamidis Meglumine Soft Capsules Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Tafamidis Meglumine Soft Capsules Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Tafamidis Meglumine Soft Capsules Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Tafamidis Meglumine Soft Capsules Industry Trends
  2. 2.2 Tafamidis Meglumine Soft Capsules Industry Drivers
  3. 2.3 Tafamidis Meglumine Soft Capsules Industry Opportunities and Challenges
  4. 2.4 Tafamidis Meglumine Soft Capsules Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Tafamidis Meglumine Soft Capsules Revenue (2021-2026)
  2. 3.2 Global Top Players by Tafamidis Meglumine Soft Capsules Sales (2021-2026)
  3. 3.3 Global Top Players by Tafamidis Meglumine Soft Capsules Price (2021-2026)
  4. 3.4 Global Tafamidis Meglumine Soft Capsules Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Tafamidis Meglumine Soft Capsules Major Company Production Sites & Headquarters
  6. 3.6 Global Tafamidis Meglumine Soft Capsules Company, Product Type & Application
  7. 3.7 Global Tafamidis Meglumine Soft Capsules Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Tafamidis Meglumine Soft Capsules Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Tafamidis Meglumine Soft Capsules Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Tafamidis Meglumine Soft Capsules Tier 1, Tier 2, and Tier 3
4 Tafamidis Meglumine Soft Capsules Regional Status and Outlook
  1. 4.1 Global Tafamidis Meglumine Soft Capsules Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Tafamidis Meglumine Soft Capsules Historic Market Size by Region
  3. 4.2.1 Global Tafamidis Meglumine Soft Capsules Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Tafamidis Meglumine Soft Capsules Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Tafamidis Meglumine Soft Capsules Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Tafamidis Meglumine Soft Capsules Forecasted Market Size by Region
  7. 4.3.1 Global Tafamidis Meglumine Soft Capsules Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Tafamidis Meglumine Soft Capsules Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Tafamidis Meglumine Soft Capsules Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Tafamidis Meglumine Soft Capsules by Application
  1. 5.1 Tafamidis Meglumine Soft Capsules Market by Application
  2. 5.1.1 Retail Pharmacies
  3. 5.1.2 Hospital and Clinic
  4. 5.1.3 Other
  5. 5.2 Global Tafamidis Meglumine Soft Capsules Market Size by Application
  6. 5.2.1 Global Tafamidis Meglumine Soft Capsules Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Tafamidis Meglumine Soft Capsules Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Tafamidis Meglumine Soft Capsules Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Tafamidis Meglumine Soft Capsules Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Tafamidis Meglumine Soft Capsules Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Tafamidis Meglumine Soft Capsules Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Tafamidis Meglumine Soft Capsules Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Tafamidis Meglumine Soft Capsules Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Chia Tai Tianqing Pharmaceutical
  2. 6.1.1 Chia Tai Tianqing Pharmaceutical Company Information
  3. 6.1.2 Chia Tai Tianqing Pharmaceutical Business Overview
  4. 6.1.3 Chia Tai Tianqing Pharmaceutical Tafamidis Meglumine Soft Capsules Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Chia Tai Tianqing Pharmaceutical Tafamidis Meglumine Soft Capsules Product Portfolio
  6. 6.1.5 Chia Tai Tianqing Pharmaceutical Recent Developments
  7. 6.2 Qilu Pharmaceutical
  8. 6.2.1 Qilu Pharmaceutical Company Information
  9. 6.2.2 Qilu Pharmaceutical Business Overview
  10. 6.2.3 Qilu Pharmaceutical Tafamidis Meglumine Soft Capsules Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Qilu Pharmaceutical Tafamidis Meglumine Soft Capsules Product Portfolio
  12. 6.2.5 Qilu Pharmaceutical Recent Developments
  13. 6.3 Pfizer
  14. 6.3.1 Pfizer Company Information
  15. 6.3.2 Pfizer Business Overview
  16. 6.3.3 Pfizer Tafamidis Meglumine Soft Capsules Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Pfizer Tafamidis Meglumine Soft Capsules Product Portfolio
  18. 6.3.5 Pfizer Recent Developments
7 North America by Country
  1. 7.1 North America Tafamidis Meglumine Soft Capsules Sales by Country
  2. 7.1.1 North America Tafamidis Meglumine Soft Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Tafamidis Meglumine Soft Capsules Sales by Country (2021-2026)
  4. 7.1.3 North America Tafamidis Meglumine Soft Capsules Sales Forecast by Country (2027-2032)
  5. 7.2 North America Tafamidis Meglumine Soft Capsules Market Size by Country
  6. 7.2.1 North America Tafamidis Meglumine Soft Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Tafamidis Meglumine Soft Capsules Market Size by Country (2021-2026)
  8. 7.2.3 North America Tafamidis Meglumine Soft Capsules Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Tafamidis Meglumine Soft Capsules Sales by Country
  2. 8.1.1 Europe Tafamidis Meglumine Soft Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Tafamidis Meglumine Soft Capsules Sales by Country (2021-2026)
  4. 8.1.3 Europe Tafamidis Meglumine Soft Capsules Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Tafamidis Meglumine Soft Capsules Market Size by Country
  6. 8.2.1 Europe Tafamidis Meglumine Soft Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Tafamidis Meglumine Soft Capsules Market Size by Country (2021-2026)
  8. 8.2.3 Europe Tafamidis Meglumine Soft Capsules Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Tafamidis Meglumine Soft Capsules Sales by Country
  2. 9.1.1 Asia-Pacific Tafamidis Meglumine Soft Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Tafamidis Meglumine Soft Capsules Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Tafamidis Meglumine Soft Capsules Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Tafamidis Meglumine Soft Capsules Market Size by Country
  6. 9.2.1 Asia-Pacific Tafamidis Meglumine Soft Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Tafamidis Meglumine Soft Capsules Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Tafamidis Meglumine Soft Capsules Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Tafamidis Meglumine Soft Capsules Sales by Country
  2. 10.1.1 South America Tafamidis Meglumine Soft Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Tafamidis Meglumine Soft Capsules Sales by Country (2021-2026)
  4. 10.1.3 South America Tafamidis Meglumine Soft Capsules Sales Forecast by Country (2027-2032)
  5. 10.2 South America Tafamidis Meglumine Soft Capsules Market Size by Country
  6. 10.2.1 South America Tafamidis Meglumine Soft Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Tafamidis Meglumine Soft Capsules Market Size by Country (2021-2026)
  8. 10.2.3 South America Tafamidis Meglumine Soft Capsules Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Tafamidis Meglumine Soft Capsules Sales by Country
  2. 11.1.1 Middle East and Africa Tafamidis Meglumine Soft Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Tafamidis Meglumine Soft Capsules Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Tafamidis Meglumine Soft Capsules Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Tafamidis Meglumine Soft Capsules Market Size by Country
  6. 11.2.1 Middle East and Africa Tafamidis Meglumine Soft Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Tafamidis Meglumine Soft Capsules Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Tafamidis Meglumine Soft Capsules Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Tafamidis Meglumine Soft Capsules Value Chain Analysis
  2. 12.1.1 Tafamidis Meglumine Soft Capsules Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Tafamidis Meglumine Soft Capsules Production Mode & Process
  7. 12.2 Tafamidis Meglumine Soft Capsules Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Tafamidis Meglumine Soft Capsules Distributors
  10. 12.2.3 Tafamidis Meglumine Soft Capsules Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst